- Assay (HPLC): ≥95.0%
- Water Content (KF): ≤0.5%
- Appearance: Off-white to light brown crystalline solid
- Related Substances: Total impurities ≤5.0%
- Residue on Evaporation: ≤0.1%
- Heavy Metals (as Pb): ≤10 ppm
- Melting Point: Not specified


Applications
6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid is a critical fused heterocyclic pharmaceutical intermediate. It features a bromo substituent and a carboxylic acid group on the imidazo[1,2-a]pyridine core, enabling diverse functionalization. Widely utilized in Suzuki-Miyaura coupling, nucleophilic substitution, and decarboxylation reactions for the synthesis of targeted anticancer agents, kinase inhibitors, and central nervous system (CNS) therapeutics. The bromo group serves as a versatile coupling site, while the carboxylic acid moiety facilitates conjugation and molecular solubility tuning. Also applied in medicinal chemistry research, agrochemical intermediate development, and complex heterocyclic molecule construction.
Safety
Harmful if swallowed; causes skin irritation and serious eye irritation; may cause respiratory irritation. Avoid inhalation of dust, direct skin and eye contact. Handle in a fume hood with chemical-resistant gloves, safety goggles, and a dust respirator. Store tightly sealed in a cool, dry, and well-ventilated place, protected from moisture and heat. In case of contact, rinse skin/eyes immediately with plenty of running water for 15 minutes. Dispose of waste as hazardous chemical waste; do not discharge into the environment.
...